1 / 8

Anti-Covid nasal spray in approval queue could be game changer for India: Scient

SaNOtize is planning to submit emergency use functions to regulatory authorities within the UK and Canada for the therapy and prevention of Covid-19. Read more: https://bit.ly/3bawH9c<br>

mudfuse
Download Presentation

Anti-Covid nasal spray in approval queue could be game changer for India: Scient

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Welcome

  2. Anti-Covid nasal spray in approval queue could be game changer for India: Scientist

  3. Canada-based pharmaceutical agency SaNOtize has filed for emergency approval in the UK and Canada for its nitric oxide nasal spray. The corporate says that the spray kills 99.9 percent of the virus that causes Covid-19 and has no confirmed negative effects.

  4. SaNOtize, a Canada-based pharmaceutical agency, has sought emergency approval from the UK and Canada for using its nitric oxide nasal spray. The corporate claims that the nasal spray can be utilized as an efficient therapy for Covid-19 because it kills 99.9 per cent of the virus.

  5. A self-administered nitric oxide nasal spray (NONS) made by Vancouver-based biotech agency SaNOtize has been discovered to dramatically cut back Covid-19 viral load in contaminated sufferers after finishing early-stage medical trials in Canada and, most just lately, the UK.

  6. Thank You

More Related